Subclassifications Of Assets, Liabilities And Equities [Abstract]

OSE Immunotherapeutics - Filing #2813125

Concept	As at 2022-12-31	As at 2021-12-31	As at 2020-12-31
Subclassifications of assets, liabilities and equities [abstract]
Property, plant and equipment [abstract]
Property, plant and equipment	743,000 EUR	926,000 EUR	—
Intangible assets and goodwill [abstract]
Intangible assets other than goodwill [abstract]
Intangible assets other than goodwill	48 784 EUR	51 122 EUR	—
Trade and other current receivables [abstract]
Current trade receivables	403,000 EUR	772,000 EUR	—
Categories of non-current financial assets [abstract]
Non-current financial assets	635,000 EUR	936,000 EUR	—
Cash and cash equivalents [abstract]
Cash equivalents [abstract]
Short-term deposits, classified as cash equivalents	2,000 EUR	—	—
Cash and cash equivalents	25 620 EUR	33 579 EUR	29 368 EUR
Miscellaneous current assets [abstract]
Other current assets	11 177 EUR	9 854 EUR	—
Borrowings [abstract]
Non-current portion of non-current borrowings	37 231 EUR	30 801 EUR	—
Current borrowings and current portion of non-current borrowings [abstract]
Current borrowings and current portion of non-current borrowings	3 093 EUR	1 611 EUR	—
Non-current portion of non-current borrowings, by type [abstract]
Current borrowings and current portion of non-current borrowings, by type [abstract]
Trade and other current payables [abstract]
Current trade payables	8 539 EUR	9 607 EUR	—
Current payables on social security and taxes other than income tax	2 916 EUR	3 724 EUR	—
Miscellaneous current liabilities [abstract]
Other current liabilities	816,000 EUR	1 050 EUR	—
Issued capital [abstract]
Issued capital	3 705 EUR	3 705 EUR	—
Net assets (liabilities) [abstract]
Assets	91 781 EUR	101 876 EUR	—
Net current assets (liabilities) [abstract]
Current assets	37 200 EUR	44 206 EUR	—
Current liabilities	16 268 EUR	16 761 EUR	—
Assets less current liabilities [abstract]